Position in ADCT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$290,212
-$417,916 QoQ
Shares Held
77,390
-56.3% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Walleye Capital LLC holds $49,633,459 across 26 Drug Manufacturers - Specialty & Generic names. ADCT ranks #17 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
183,075 | $14,078,467 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
325,753 | $6,762,632 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
1,177,370 | $6,357,798 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
260,817 | $4,830,330 | |
| 5 | BIOA |
BioAge Labs, Inc.
|
151,674 | $2,652,778 | |
| 6 | ZTS |
Zoetis Inc.
|
21,328 | $2,521,182 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
584,977 | $2,427,654 | |
| 8 | ETON |
Eton Pharmaceuticals, Inc.
|
81,963 | $2,022,846 |
All Filings in ADCT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $290,212 | 77,390 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $708,128 | 177,032 | Shares | Sole | 2025-11-14 | |
| 2022-12-31 | $1,972,293 | 513,618 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,355,987 | 696,263 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,065,165 | 888,700 | Shares | Sole | 2022-08-19 | |
| 2022-03-31 | $3,648,320 | 248,354 | Shares | Sole | 2022-05-27 | |
| 2021-12-31 | $918,655 | 45,478 | Shares | Sole | 2022-05-27 | |
| No filing history on record for this holder in this stock. | ||||||